You just read:

Sophiris Bio Announces that the First Patient Has Been Dosed in Phase 2b Study of Topsalysin in Patients with Clinically Significant Localized Prostate Cancer

News provided by

Sophiris Bio Inc.

08 Jun, 2017, 08:00 ET